1. Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices. Issue 3 (29th June 2020) Authors: Younossi, Zobair M.; Corey, Kathleen E.; Alkhouri, Naim; Noureddin, Mazen; Jacobson, Ira; Lam, Brian; Clement, Stephen; Basu, Rita; Gordon, Stuart C.; Ravendhra, Natarajan; Puri, Puneet; Rinella, Mary; Scudera, Peter; Singal, Ashwani K.; Henry, Linda Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 3(2020) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis. (24th January 2016) Authors: Kao, Jia‐Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng‐Yuan; Roberts, Stuart K.; Lee, Youn‐Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie Journal: Liver international Issue: Volume 36:Number 7(2016) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus. (January 2018) Authors: Adinolf, Luigi Elio; Jacobson, Ira; Bondin, Mark; Cacoub, Patrice Journal: Antiviral therapy Issue: Volume 23:Supplement 1(2018) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy. (8th October 2012) Authors: Nelson, David R.; Jensen, Donald M.; Sulkowski, Mark S.; Everson, Greg; Fried, Michael W.; Gordon, Stuart C.; Jacobson, Ira; Reau, Nancy S.; Sherman, Kenneth; Terrault, Nora; Thomas, David Other Names: Almasio Piero Luigi Academic Editor. Journal: Hepatitis research and treatment Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies. Issue 5 (21st April 2020) Authors: Whitsett, Maureen; Feldman, David M.; Jacobson, Ira Journal: Liver transplantation Issue: Volume 26:Issue 5(2020) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Issue 20 (15th July 2015) Authors: Kim, W. Ray; Loomba, Rohit; Berg, Thomas; Aguilar Schall, Raul E.; Yee, Leland J.; Dinh, Phillip V.; Flaherty, John F.; Martins, Eduardo B.; Therneau, Terry M.; Jacobson, Ira; Fung, Scott; Gurel, Selim; Buti, Maria; Marcellin, Patrick Journal: Cancer Issue: Volume 121:Issue 20(2015) Page Start: 3631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liver Imaging After Successful Treatment in HCV‐infected Patients with Cirrhosis: An Updated Retrospective Study: 802. (October 2016) Authors: Jilani, Omar K.; Ernstoff, Nathaniel; Jacobson, Ira Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. (12th April 2012) Authors: Welsch, Christoph; Jesudian, Arun; Zeuzem, Stefan; Jacobson, Ira Journal: Gut Issue: Volume 61(2012)Supplement 1 Page Start: i36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes. (5th April 2019) Authors: Younossi, Zobair M; Stepanova, Maria; Jacobson, Ira; Muir, Andrew J; Pol, Stanislas; Zeuzem, Stefan; Younes, Ziad; Herring, Robert; Lawitz, Eric; Younossi, Issah; Racila, Andrei Journal: Clinical infectious diseases Issue: Volume 70:Number 4(2020) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Once‐daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment‐naïve genotype 1 hepatitis C: The randomized PILLAR study. Issue 6 (11th October 2013) Authors: Fried, Michael W.; Buti, Maria; Dore, Gregory J.; Flisiak, Robert; Ferenci, Peter; Jacobson, Ira; Marcellin, Patrick; Manns, Michael; Nikitin, Igor; Poordad, Fred; Sherman, Morris; Zeuzem, Stefan; Scott, Jane; Gilles, Leen; Lenz, Oliver; Peeters, Monika; Sekar, Vanitha; De, Goedele; Beumont‐Mauvi... Journal: Hepatology Issue: Volume 58:Issue 6(2013:Dec.) Page Start: 1918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗